Molde Hospital
16
4
7
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
13%
2 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer
Role: collaborator
A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease
Role: collaborator
Candesartan for Migraine Prevention:
Role: collaborator
Coronary CT Angiography in Non ST-elevation Myocardial Infarction
Role: collaborator
Optimizing the Treatment Strategy for Age-related Macular Degeneration
Role: collaborator
Personalized Training for People With Rare Neuromuscular Disorders
Role: collaborator
The Norwegian Immunotherapy in Multiple Myeloma Study
Role: collaborator
The Norwegian Cerebral Venous Thrombosis Study
Role: collaborator
The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery
Role: collaborator
New-onset Severe Headache After Covid-19 Vaccine
Role: collaborator
Postoperative Controls of Ventilation Tubes in Children - by General Practitioner or Otolaryngologist?
Role: collaborator
The Corona Study of Middle Norway
Role: collaborator
Norwegian Capture the Fracture Initiative
Role: collaborator
Atrial Fibrillation in Cryptogenic Stroke and TIA
Role: collaborator
Prediction and Secondary Prevention of Fractures
Role: collaborator
Return to Work After Potential Severe Injury
Role: collaborator
All 16 trials loaded